Skip to main content

Pharmaceutical Sales 2010

The following is a list of the top 200 Drugs by units sold in 2010, listed by U.S. units sold and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2010 by Units Sold

(By Sales)

View data for: 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Rxs (000) % Change 2009
1 Lipitor Viatris 37,523 -11.3%
2 Nexium AstraZeneca 25,872 -1.7%
3 Plavix Bristol-Myers Squibb Company 25,000 -2.1%
4 Singulair Merck 24,666 -0.5%
5 Lexapro Actavis Pharma, Inc. 23,000 -4.1%
6 (2) Crestor AstraZeneca 20,945 14.4%
7 Synthroid Abbott Laboratories 20,272 -4.5%
8 (2) ProAir HFA Teva Pharmaceuticals USA, Inc. 18,616 -15.7%
9 Advair Diskus GlaxoSmithKline 16,580 -4.7%
10 (1) Cymbalta Eli Lilly and Company 14,591 -1.3%
11 (1) Diovan Novartis Pharmaceuticals Corporation 14,360 -3.2%
12 (18) Ventolin HFA GlaxoSmithKline 13,523 68.4%
13 (2) Diovan HCT Novartis Pharmaceuticals Corporation 11,480 -6.7%
14 (2) Actos Takeda Pharmaceutical Company Limited 11,193 -3.5%
15 (3) Seroquel AstraZeneca 10,260 -6.9%
16 (3) Levaquin Janssen Pharmaceuticals, Inc. 9,322 -12.4%
17 (8) Lantus Sanofi 8,960 -5.9%
18 (8) Nasonex Merck 8,834 -7.9%
19 (4) Viagra Viatris 8,829 -7.4%
20 (7) Lyrica Viatris 8,714 -5.1%
21 (3) Celebrex Viatris 8,643 -9.8%
22 (10) Concerta Janssen Pharmaceuticals, Inc. 7,949 2.7%
23 (12) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. 7,738 5.3%
24 (4) Premarin tabs Pfizer Inc. 7,691 -14.7%
25 (13) Effexor XR Viatris 7,603 -44.1%
26 (6) Tricor Abbott Laboratories 7,588 -23.1%
27 (2) Zetia Merck 7,398 -14.8%
28 (6) Vytorin Merck 7,165 -25.3%
29 (12) OxyContin Purdue Pharma LP 6,869 7.5%
30 (9) Abilify Bristol-Myers Squibb Company 6,799 6.0%
31 (32) Loestrin 24 Fe Allergan plc 6,693 65.5%
32 (21) Vyvanse Takeda Pharmaceutical Company Limited 6,604 31.3%
33 (7) Cialis Eli Lilly and Company 6,584 5.2%
34 (16) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 6,476 24.2%
35 (3) Aricept Eisai Inc. 6,252 -4.0%
36 Benicar Daiichi Sankyo 6,098 -10.8%
37 (8) Januvia Merck 5,919 5.5%
38 (9) Lunesta Sepracor Inc. 5,714 7.5%
39 (2) Ambien CR Sanofi 5,687 -16.7%
40 (8) Niaspan Abbott Laboratories 5,618 5.6%
41 (3) Xalatan Viatris 5,516 -3.3%
42 Levoxyl King Pharmaceuticals, Inc. 5,452 -16.9%
43 Benicar HCT Daiichi Sankyo 5,215 -12.7%
44 (13) Flovent HFA GlaxoSmithKline 5,047 9.5%
45 (11) NuvaRing Merck 4,756 1.7%
46 () Lovaza GlaxoSmithKline 4,583 12.0%
47 (26) Yaz Bayer HealthCare Pharmaceuticals Inc. 4,567 -54.5%
48 (16) NovoLog Novo Nordisk 4,443 10.2%
49 (10) Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 4,270 -5.1%
50 (12) Namenda Actavis Pharma, Inc. 4,193 4.2%
51 (1) Detrol LA Viatris 4,160 -18.8%
52 (13) Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 4,157 8.7%
53 (27) Lantus SoloSTAR Sanofi 4,035 40.5%
54 (8) Proventil HFA Merck 3,952 -30.3%
55 Aciphex Eisai Inc. 3,897 -18.6%
56 (2) Avapro Bristol-Myers Squibb Company 3,811 -17.2%
57 (41) Bystolic Actavis Pharma, Inc. 3,666 62.6%
58 (7) Adderall XR Takeda Pharmaceutical Company Limited 3,625 -29.6%
59 (30) Symbicort AstraZeneca 3,618 42.1%
60 (8) Zyprexa Eli Lilly and Company 3,616 -0.9%
61 (56) Trilipix Abbott Laboratories 3,608 84.2%
62 (2) Boniva Genentech, Inc. 3,524 -14.7%
63 (9) Avodart GlaxoSmithKline 3,466 0.3%
64 (22) Glipizide XL Viatris 3,423 24.2%
65 (36) Pristiq Pfizer Inc. 3,412 49.9%
66 (5) Lidoderm Endo Pharmaceuticals Inc. 3,402 -2.6%
67 (2) Humalog Eli Lilly and Company 3,343 -6.2%
68 (6) Vigamox Alcon Laboratories, Inc. 3,327 -1.9%
69 (2) Evista Eli Lilly and Company 3,296 -11.4%
70 (53) Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 3,132 -73.1%
71 (5) Chantix Pfizer Inc. 2,980 -20.9%
72 (2) Avalide Bristol-Myers Squibb Company 2,879 -17.6%
73 (5) Protonix Pfizer Inc. 2,848 -9.2%
74 (43) Cozaar Merck 2,837 -64.0%
75 (9) Vivelle-DOT Novartis Pharmaceuticals Corporation 2,832 1.6%
76 (12) Vesicare Astellas Pharma US, Inc. 2,814 6.2%
77 (17) Prempro Pfizer Inc. 2,702 11.7%
78 (1) Avelox Bayer HealthCare Pharmaceuticals Inc. 2,693 -15.1%
79 () Dexilant/Kapidex 2,675 233.3%
80 (15) Focalin XR Novartis Pharmaceuticals Corporation 2,667 11.8%
81 Strattera Eli Lilly and Company 2,606 -7.8%
82 (1) Xopenex HFA Sepracor Inc. 2,584 -8.3%
83 (22) Actonel Actavis Pharma, Inc. 2,558 -37.6%
84 (36) Travatan Z Alcon Laboratories, Inc. 2,543 33.6%
85 (34) Levemir Novo Nordisk 2,535 29.6%
86 (5) Lumigan Actavis Pharma, Inc. 2,518 2.8%
87 (18) Apri Teva Pharmaceuticals USA, Inc. 2,394 10.5%
88 (6) Levitra Bayer HealthCare Pharmaceuticals Inc. 2,359 -17.5%
89 (8) Geodon oral Viatris 2,332 0.3%
90 (6) Micardis Boehringer Ingelheim Pharmaceuticals, Inc. 2,324 2.4%
91 (16) Exforge Novartis Pharmaceuticals Corporation 2,267 6.6%
92 (5) Coumadin tabs Bristol-Myers Squibb Company 2,248 -18.6%
93 (22) Janumet Merck 2,245 14.9%
94 (18) Ciprodex otic Alcon Laboratories, Inc. 2,204 4.2%
95 (62) Valtrex GlaxoSmithKline 2,180 -71.7%
96 (15) Restasis Actavis Pharma, Inc. 2,156 3.5%
97 (74) Seroquel XR AstraZeneca 2,101 94.4%
98 (6) Micardis HCT Abbott Laboratories 2,088 -1.3%
99 (38) Actonel 150 Actavis Pharma, Inc. 2,045 12.5%
100 (7) Lotrel Novartis Pharmaceuticals Corporation 2,041 -17.4%
101 (25) Tussionex Sanofi 2,024 -39.0%
102 (16) Prometrium Solvay Pharmaceuticals, Inc. 1,989 -1.4%
103 (21) AndroGel Abbott Laboratories 1,969 6.7%
104 (4) Kariva Teva Pharmaceuticals USA, Inc. 1,967 -15.8%
105 (4) Patanol Alcon Laboratories, Inc. 1,960 -7.4%
107 (58) Hyzaar Merck 1,899 -64.7%
108 (35) Thyroid, Armour Actavis Pharma, Inc. 1,893 -43.6%
109 (17) Nasacort AQ Sanofi 1,807 -25.6%
110 (12) Coreg CR GlaxoSmithKline 1,782 -7.2%
112 (35) Pataday Alcon Laboratories, Inc. 1,755 16.4%
113 (11) Xyzal Sanofi 1,747 -24.4%
114 (11) Humulin N Eli Lilly and Company 1,715 -4.4%
115 (16) Vagifem Novo Nordisk 1,650 -3.1%
116 (62) Toprol XL AstraZeneca 1,650 -67.6%
117 (7) Byetta Amylin Pharmaceuticals, Inc. 1,638 -22.1%
118 (21) NovoLog Mix 70/30 Novo Nordisk 1,633 6.9%
119 (11) Veramyst GlaxoSmithKline 1,584 -9.9%
120 (39) Azor Daiichi Sankyo 1,562 21.5%
121 (13) Caduet Viatris 1,561 -26.2%
122 (33) Welchol Daiichi Sankyo 1,560 13.2%
123 (10) Actoplus Met Takeda Pharmaceutical Company Limited 1,531 -3.4%
124 (10) Provigil Cephalon, Inc. 1,517 -29.1%
125 (11) Epipen Viatris 1,512 -1.1%
126 (6) Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc. 1,497 -6.9%
127 (11) Dilantin Viatris 1,475 -4.9%
128 (24) Enablex Actavis Pharma, Inc. 1,466 3.0%
129 (13) Alphagan P Actavis Pharma, Inc. 1,461 -27.0%
130 (11) Premarin vaginal Pfizer Inc. 1,452 -4.6%
131 (4) Xopenex Akorn, Inc. 1,444 -20.6%
132 (14) Uroxatral Concordia Pharmaceuticals Inc. 1,419 -4.4%
133 (10) Asmanex Merck 1,412 -4.0%
134 (10) Prevacid SoluTab Takeda Pharmaceutical Company Limited 1,393 -4.9%
135 (29) Moviprep Salix Pharmaceuticals, Inc. 1,363 21.7%
136 (33) Avandia GlaxoSmithKline 1,345 -40.0%
137 (24) Tekturna Novartis Pharmaceuticals Corporation 1,321 5.3%
138 (11) Propecia Merck 1,319 -9.4%
139 (6) Ortho Evra Janssen Pharmaceuticals, Inc. 1,312 -13.9%
140 (35) Solodyn Medicis Pharmaceutical Corporation 1,311 19.1%
141 (4) Humulin 70/30 Eli Lilly and Company 1,298 -14.7%
142 (36) Lanoxin GlaxoSmithKline 1,265 -41.2%
143 (8) Asacol Actavis Pharma, Inc. 1,258 -19.1%
144 (130) Prevacid Takeda Pharmaceutical Company Limited 1,248 -90.5%
145 (17) Atacand AstraZeneca 1,238 -29.2%
146 (27) Nitrostat Viatris 1,220 17.8%
147 (40) Combigan Actavis Pharma, Inc. 1,169 27.8%
148 () Halflytely bwl prep 1,128 -28.9%
149 (14) Relpax Viatris 1,113 -8.2%
150 (20) Novolin 70/30 Novo Nordisk 1,106 -1.0%
151 (18) Femara Novartis Pharmaceuticals Corporation 1,098 -0.6%
152 (118) Tamiflu Genentech, Inc. 1,094 -85.3%
153 (14) Zovirax topical GlaxoSmithKline 1,075 -5.1%
154 (4) Lovenox Sanofi 1,057 -22.2%
155 (13) Zymar Allergan plc 1,055 -31.5%
156 (10) Maxalt Merck 1,028 -7.5%
157 (25) Estrace vaginal Actavis Pharma, Inc. 1,024 7.4%
158 () Exelon Patch Novartis Pharmaceuticals Corporation 1,008 24.9%
159 () Intuniv Takeda Pharmaceutical Company Limited 983 NA
160 Allegra-D 24 Hour Sanofi 975 -25.3%
161 () Astepro 0.15 955 NA
162 (12) Maxalt MLT Merck 949 -8.3%
163 (34) Arimidex AstraZeneca 946 -45.5%
164 (15) Amitiza Takeda Pharmaceutical Company Limited 941 -1.8%
165 () Doryx Actavis Pharma, Inc. 939 13.4%
166 (15) Differin Galderma Laboratories, L.P. 913 -37.0%
167 (27) Clarinex Merck 906 -43.2%
168 (24) Lotemax Bausch & Lomb Inc. 905 1.3%
169 (46) Astelin Meda U.S. 896 -52.5%
170 (27) Transderm-Scop Baxter International Inc. 883 4.6%
171 (10) Humulin R Eli Lilly and Company 878 -6.9%
172 (19) Levothroid Actavis Pharma, Inc. 869 -40.2%
173 () Advair HFA GlaxoSmithKline 868 22.0%
174 (10) Truvada Gilead Sciences, Inc. 866 -7.5%
175 () Nuvigil Cephalon, Inc. 852 194.8%
176 () SF 5000 Plus Cypress Pharmaceutical, Inc. 838 12.3%
177 (9) Yasmin 28 Bayer HealthCare Pharmaceuticals Inc. 837 -28.7%
178 (1) Bactroban GlaxoSmithKline 824 -17.7%
179 () Ranexa Gilead Sciences, Inc. 816 32.8%
180 (15) Metadate CD Lannett Company, Inc. 810 -6.8%
181 (25) Lamictal GlaxoSmithKline 801 -42.3%
182 (16) Atrovent HFA Boehringer Ingelheim Pharmaceuticals, Inc. 800 -5.7%
183 () Simcor Abbott Laboratories 800 14.9%
184 () Opana ER Endo Pharmaceuticals Inc. 794 39.4%
185 (23) Rhinocort Aqua AstraZeneca 774 -36.8%
186 (4) Humalog Mix 75/25 Pen Eli Lilly and Company 769 -14.7%
187 () Carafate Actavis Pharma, Inc. 764 7.5%
188 (8) Norvir Abbott Laboratories 762 -10.9%
189 () Aspir-Low Major Pharmaceuticals 760 2.2%
190 (36) BenzaClin Sanofi 759 -45.3%
191 (101) Skelaxin Elan Corporation plc 759 -70.2%
192 (6) Duac Care System GlaxoSmithKline 755 -15.4%
193 (17) Wellbutrin XL Bausch Health Companies Inc. 753 -26.7%
194 (1) Arthrotec Pfizer Inc. 752 -15.7%
195 () Epiduo Galderma Laboratories, L.P. 742 43.5%
196 () Pulmicort Flexhaler AstraZeneca 735 -6.7%
197 () Omnaris Sepracor Inc. 734 79.3%
198 () Ortho Tri-Cyclen Janssen Pharmaceuticals, Inc. 732 16.1%
199 (5) Prandin Novo Nordisk 726 -15.0%
200 () Nevanac Alcon Laboratories, Inc. 725 16.1%

Source: Verispan, VONA

(By Sales)

View data for: 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012